Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

  • This share is currently suspended. It was suspended at a price of 1.2699
  • There is currently no data for ONC

Oncimmune News

UK TRADING UPDATE SUMMARY: Novacyt Unveils New Test For Mink Covid
14 Dec 2020

UK TRADING UPDATE SUMMARY: Novacyt Unveils New Test For Mink Covid

UK TRADING UPDATE SUMMARY: Novacyt Unveils New Test For Mink Covid

Oncimmune signs two NHS contracts, has NICE guidance published
14 Dec 2020

Oncimmune signs two NHS contracts, has NICE guidance published

(Sharecast News) - Oncimmune has signed a commercial contract to supply its 'EarlyCDT Lung' blood test to NHS Norfolk & Waveney Clinical Commissio...

UK Shareholder Meetings Calendar - Next 7 Days
16 Nov 2020

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

UK TRADING UPDATE SUMMARY: Mereo To Delist From AIM Amid Nasdaq Focus
11 Nov 2020

UK TRADING UPDATE SUMMARY: Mereo To Delist From AIM Amid Nasdaq Focus

UK TRADING UPDATE SUMMARY: Mereo To Delist From AIM Amid Nasdaq Focus

Oncimmune enters deal with Augmenta to profile plasma samples
11 Nov 2020

Oncimmune enters deal with Augmenta to profile plasma samples

(Sharecast News) - Immunodiagnostics group Oncimmune has signed a new master service agreement with Augmenta Bioworks, it announced on Wednesday, to p...

IN BRIEF: Oncimmune Annual Loss Widens As Expenses Climb
30 Oct 2020

IN BRIEF: Oncimmune Annual Loss Widens As Expenses Climb

IN BRIEF: Oncimmune Annual Loss Widens As Expenses Climb

UK TRADING UPDATE SUMMARY: Shoe Zone Ends Financial Year On Back Foot
28 Oct 2020

UK TRADING UPDATE SUMMARY: Shoe Zone Ends Financial Year On Back Foot

UK TRADING UPDATE SUMMARY: Shoe Zone Ends Financial Year On Back Foot

IN BRIEF: Oncimmune In Covid Antibody Profiling Deal With Cedars-Sinai
13 Oct 2020

IN BRIEF: Oncimmune In Covid Antibody Profiling Deal With Cedars-Sinai

IN BRIEF: Oncimmune In Covid Antibody Profiling Deal With Cedars-Sinai